Štingl Jan, Hylmarová Julie, Lengerová Martina, Maláska Jan, Stašek Jan
Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic.
Department of Pathological Anatomy, University Hospital Brno, 625 00 Brno, Czech Republic.
Diagnostics (Basel). 2022 Aug 12;12(8):1944. doi: 10.3390/diagnostics12081944.
Cryptococcal superinfection is a rare but potentially fatal complication, especially if its detection and subsequent treatment are delayed. Histopathological findings of pulmonary parenchyma from a deceased patient with these complications were acquired. Quite interestingly, only a minimal inflammatory reaction could be seen in an individual with no previously known immune suppression, indicating a disturbance of the immune system. This finding was well in concordance with the described changes in cellular immunity in COVID-19. We report the case of a 60 year old male with critical coronavirus disease 2019 (COVID-19) complicated by cryptococcal pneumonia and multiorgan failure. Both X-ray and CT scans revealed lung infiltrates corresponding with COVID-19 infection early after the onset of symptoms. Despite receiving standard treatment, the patient progressed into multiple organ failure, requiring mechanical ventilation, circulatory support, and haemodialysis. was detected by subsequent BAL, and specific antifungal treatment was instituted. His clinical status deteriorated despite all treatment, and he died of refractory circulatory failure after 21 days from hospital admission. Histopathological findings confirmed severe diffuse alveolar damage (DAD) caused by COVID-19 and cryptococcal pneumonia. Timely diagnosis of cryptococcal superinfection may be challenging; therefore, PCR panels detecting even uncommon pathogens should be implemented while taking care of critical COVID-19 patients.
隐球菌二重感染是一种罕见但可能致命的并发症,尤其是在其检测及后续治疗延迟的情况下。获取了一名患有这些并发症的已故患者肺实质的组织病理学检查结果。非常有趣的是,在一名既往无已知免疫抑制的个体中仅可见轻微的炎症反应,这表明免疫系统受到了干扰。这一发现与新冠病毒病(COVID-19)中所描述的细胞免疫变化高度一致。我们报告了一例60岁男性重症2019冠状病毒病(COVID-19)合并隐球菌肺炎及多器官功能衰竭的病例。症状出现后早期,X线和CT扫描均显示与COVID-19感染相符的肺部浸润影。尽管接受了标准治疗,患者仍进展为多器官功能衰竭,需要机械通气、循环支持和血液透析。随后通过支气管肺泡灌洗(BAL)检测到了隐球菌,遂开始进行特异性抗真菌治疗。尽管进行了所有治疗,患者的临床状况仍恶化,入院21天后死于难治性循环衰竭。组织病理学检查结果证实了由COVID-19和隐球菌肺炎导致的严重弥漫性肺泡损伤(DAD)。隐球菌二重感染的及时诊断可能具有挑战性;因此,在救治重症COVID-19患者时应采用能检测甚至罕见病原体的聚合酶链反应(PCR)检测板。